| New insights in Type I and II CD 20 antibody mechanisms‐of‐action with a panel of novel CD 20 antibodies S Meyer, M Evers, JHM Jansen, J Buijs, B Broek, SE Reitsma, P Moerer, ... British Journal of Haematology 180 (6), 808-820, 2018 | 59 | 2018 |
| Factor XII activation promotes platelet consumption in the presence of bacterial-type long-chain polyphosphate in vitro and in vivo J Zilberman-Rudenko, SE Reitsma, C Puy, RA Rigg, SA Smith, EI Tucker, ... Arteriosclerosis, thrombosis, and vascular biology 38 (8), 1748-1760, 2018 | 34 | 2018 |
| Cross-talk between the complement pathway and the contact activation system of coagulation: activated factor XI neutralizes complement factor H C Puy, J Pang, SE Reitsma, CU Lorentz, EI Tucker, D Gailani, A Gruber, ... The Journal of Immunology 206 (8), 1784-1792, 2021 | 29 | 2021 |
| Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low‐density lipoprotein receptor‐deficient mice ATP Ngo, KR Jordan, PA Mueller, MW Hagen, SE Reitsma, C Puy, ... Journal of Thrombosis and Haemostasis 19 (4), 1001-1017, 2021 | 29 | 2021 |
| Removal of the C-terminal domains of ADAMTS13 by activated coagulation factor XI induces platelet adhesion on endothelial cells under flow conditions KS Garland, SE Reitsma, T Shirai, J Zilberman-Rudenko, EI Tucker, ... Frontiers in Medicine 4, 232, 2017 | 18 | 2017 |
| Revised model of the tissue factor pathway of thrombin generation: role of the feedback activation of FXI HHS Lakshmanan, A Estonilo, SE Reitsma, AR Melrose, J Subramanian, ... Journal of Thrombosis and Haemostasis 20 (6), 1350-1363, 2022 | 16 | 2022 |
| Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function I Parra-Izquierdo, AR Melrose, J Pang, HHS Lakshmanan, SE Reitsma, ... Platelets 33 (3), 404-415, 2022 | 16 | 2022 |
| The toll-like receptor 2 ligand Pam2CSK4 activates platelet nuclear factor-κB and Bruton’s tyrosine kinase signaling to promote platelet-endothelial cell interactions I Parra-Izquierdo, HHS Lakshmanan, AR Melrose, J Pang, TJ Zheng, ... Frontiers in immunology 12, 729951, 2021 | 13 | 2021 |
| Role of platelets in regulating activated coagulation factor XI activity SE Reitsma, J Pang, V Raghunathan, JJ Shatzel, CU Lorentz, EI Tucker, ... American Journal of Physiology-Cell Physiology 320 (3), C365-C374, 2021 | 13 | 2021 |
| Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity TJ Zheng, TCL Kohs, PA Mueller, J Pang, SE Reitsma, I Parra-Izquierdo, ... Blood Advances 7 (8), 1366-1378, 2023 | 7 | 2023 |
| Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology TJ Zheng, I Parra-Izquierdo, SE Reitsma, MC Heinrich, MK Larson, ... American Journal of Physiology-Cell Physiology 323 (4), C1231-C1250, 2022 | 6 | 2022 |
| Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function SE Reitsma, HHS Lakshmanan, J Johnson, J Pang, I Parra-Izquierdo, ... American Journal of Physiology-Cell Physiology 322 (3), C370-C381, 2022 | 6 | 2022 |
| Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency SE Reitsma, LA Holle, EG Bouck, DM Monroe, AE Mast, J Burthem, ... Journal of Thrombosis and Haemostasis 21 (3), 467-479, 2023 | 5 | 2023 |
| Effect of pneumatic tubing system transport on platelet apheresis units J Zilberman-Rudenko, FZ Zhao, SE Reitsma, A Mitrugno, J Pang, ... Cardiovascular engineering and technology 9, 515-527, 2018 | 4 | 2018 |
| Activated FXI regulates the catalytic activity of ADAMTS13 by removing the CUB domains C Puy, KS Garland, T Shirai, SE Reitsma, J Zilberman-Rudenko, A Gruber, ... Arteriosclerosis, Thrombosis, and Vascular Biology 37 (suppl_1), A522-A522, 2017 | 2 | 2017 |
| PB1206 Plasmin generation is impaired in patients with bleeding disorders of unknown cause D Mehic, S Reitsma, H Haslacher, M Köller, B De Laat, C Ay, I Pabinger, ... Research and Practice in Thrombosis and Haemostasis 7, 101037, 2023 | 1 | 2023 |
| Plasmin generation and fibrinolysis in adults with primary immune thrombocytopenia T Schramm, D Mehic, J Rast, SE Reitsma, M Fillitz, P Quehenberger, ... Hämostaseologie 44 (S 01), T-14-01, 2024 | | 2024 |
| PB0421 Phosphoproteomics and Systems Analysis Reveal Protein Kinase C Theta (PKCfɵ) Signaling Events Associated with the Generation of Procoagulant Platelets Y Zhang, S Reitsma, O Babur, A Melrose, J Pang, S Hodapp, A Newton, ... Research and Practice in Thrombosis and Haemostasis 7, 101670, 2023 | | 2023 |
| OC 57.2 Integrated Proteomic and Computational Approach Reveals Determinants of Bleeding Risk in Factor XI Deficiency S Reitsma, S Sindi, D Kissau, J Burthem, P Bolton-Maggs, G Gidley, ... Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
| HTRS2023. O6A. 4 Proteomic analysis reveals proteins that are differently expressed in factor XI-deficient non-bleeders and bleeders SE Reitsma, D Kissau, J Burthem, P Bolton-Maggs, G Gidley, K Hansen, ... Research and Practice in Thrombosis and Haemostasis 7, 100205, 2023 | | 2023 |
